Ani Pharmaceuticals (ANIP) FCF Payout Ratio Growth (1y) (2022 - 2025)
Ani Pharmaceuticals (ANIP) FCF Payout Ratio Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -99.44% |
| Jun 30, 2025 | -75.81% |
| Mar 31, 2025 | -49.82% |
| Dec 31, 2024 | 53.08% |
| Sep 30, 2024 | 14,608.80% |
| Jun 30, 2024 | 6.50% |
| Mar 31, 2024 | 11.90% |
| Dec 31, 2023 | 110.38% |
| Sep 30, 2023 | -88.58% |
| Jun 30, 2023 | 166.26% |
| Mar 31, 2023 | 200.88% |
| Dec 31, 2022 | -467.28% |